Results 231 to 240 of about 6,056,808 (246)

A Novel C19orf47‐AKT2 Chimeric RNA Generated by Cis‐Splicing of Adjacent Genes Is Associated With Glioblastoma Prognosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Malignant gliomas pose significant therapeutic challenges. This study aimed to identify and characterize a novel chimeric RNA in glioma and assess its clinical and functional significance for precision treatment. Methods The C19orf47‐AKT2 chimeric RNAs were identified through RNA sequencing and validated by polymerase chain reaction.
Zihan Wang, Bowen Ni, Kezhi Wu, Qi Zhang, Jinglin Guo, Runwei Yang, Ziyu Wang, Guozhong Yi, Guanglong Huang, Minyi He, Yimin Xu, Yawei Liu   +11 more
wiley   +1 more source

Team-based learning: Enhancing primary care medical education. [PDF]

Med Educ
Yerrakalva D, Saeed L, Easton G, Malekigorji M, Fisher N.   +4 more
europepmc   +1 more source

High‐Efficacy Treatment in Neuromyelitis Optica Specturm Disorder Patients With Seropositive AQP4 Antibodies—A Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To compare the effectiveness of high‐efficacy treatments (HET) and low‐efficacy treatments (LET) in NMOSD patients with anti‐aquaporin‐4 antibodies (AQP4‐ab). Methods In this multi‐center study, we analyzed 183 AQP4‐ab seropositive NMOSD patients who received immunosuppressive treatments (IST).
Xiang Li, Binbin Xue, Jia Li, Dewei Xie, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Xu Zhang, Junhui Xia, Jie Lin   +10 more
wiley   +1 more source

Crafting the Isolated Consulting Room: Practices of Independence and Collaboration of Finnish Primary Care GPs. [PDF]

Sociol Health Illn
Laisi I.
europepmc   +1 more source

Real‐World Comparison of High‐Efficacy Versus Non‐High‐Efficacy Therapies in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The choice of the first disease modifying treatment (DMT) in multiple sclerosis (MS) is a topic of great interest, and whether high‐efficacy DMTs should be the first choice remains debated. We compared treatment outcomes (no evidence of disease activity [NEDA] and its components) between treatment‐naïve relapsing–remitting MS (RRMS ...
Sarmad Al‐Araji, Marcello Moccia, Alessia Bianchi, Charmaine Yam, Weaam Hamed, Suraya Mohamud, Alan J. Thompson, Frederik Barkhof, Ahmed T. Toosy, Olga Ciccarelli   +9 more
wiley   +1 more source

An approach to heart failure for the public-sector primary care clinician. [PDF]

S Afr Fam Pract (2004)
Rossouw L, Lachman AS, Von Pressentin KB.   +2 more
europepmc   +1 more source

Impact of Telehealth on Pediatric Direct Primary Care: Is Virtually Showing Up Valuable? [PDF]

Cureus
Lee A, Belt NG, Mistovich K, Mistovich RJ, Hertz A.   +4 more
europepmc   +1 more source

Scope of practice of primary care nurses: a protocol for an umbrella review of international literature. [PDF]

BMJ Open
Lukewich J, Mathews M, Myles S, Dufour É, Asghari S, Rioux-Dubois A, Martin-Misener R, Halcomb EJ, Chiu P, Poitras ME, Leslie K, McGraw M, Ryan D, Curnew D, Meredith L, Morin A, Swab M, Braithwaite S, Macdonald D, Hedden L, Aubrey-Bassler K, Calver J, Bruneau J.   +22 more
europepmc   +1 more source

On pharmacists and primary care. [PDF]

Can Pharm J (Ott)
Paes D.
europepmc   +1 more source